Filtros : "FCF004" "Pharmaceutics" Removido: "WATANABE, II SEI" Limpar

Filtros



Refine with date range


  • Source: Pharmaceutics. Unidade: FCF

    Subjects: FARMACOCINÉTICA, FARMACODINÂMICA

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      YOUSEF, Malaz et al. In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors. Pharmaceutics, v. 16, n. 6 p. 1-13 art. 768, 2024Tradução . . Disponível em: https://dx.doi.org/10.3390/pharmaceutics16060768. Acesso em: 31 jul. 2024.
    • APA

      Yousef, M., O’Croinin, C., Le, T. S., Park, C., Zuo, J., Bou-Chacra, N. A., et al. (2024). In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors. Pharmaceutics, 16( 6 p. 1-13 art. 768). doi:10.3390/pharmaceutics16060768
    • NLM

      Yousef M, O’Croinin C, Le TS, Park C, Zuo J, Bou-Chacra NA, Davies NM, Löbenberg R. In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors [Internet]. Pharmaceutics. 2024 ; 16( 6 p. 1-13 art. 768):[citado 2024 jul. 31 ] Available from: https://dx.doi.org/10.3390/pharmaceutics16060768
    • Vancouver

      Yousef M, O’Croinin C, Le TS, Park C, Zuo J, Bou-Chacra NA, Davies NM, Löbenberg R. In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors [Internet]. Pharmaceutics. 2024 ; 16( 6 p. 1-13 art. 768):[citado 2024 jul. 31 ] Available from: https://dx.doi.org/10.3390/pharmaceutics16060768
  • Source: Pharmaceutics. Unidade: FCF

    Assunto: PLANEJAMENTO DE FÁRMACOS

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      LEON, Rosmery Merma et al. Development of a discriminative dissolution method, using in-silico tool for Hydrochlorothiazide and Valsartan tablet. Pharmaceutics, v. 15, p. 1-20 art. 1735, 2023Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics15061735. Acesso em: 31 jul. 2024.
    • APA

      Leon, R. M., Issa, M. G., Duque, M. D., Daniel, J. S. P., & Ferraz, H. G. (2023). Development of a discriminative dissolution method, using in-silico tool for Hydrochlorothiazide and Valsartan tablet. Pharmaceutics, 15, 1-20 art. 1735. doi:10.3390/pharmaceutics15061735
    • NLM

      Leon RM, Issa MG, Duque MD, Daniel JSP, Ferraz HG. Development of a discriminative dissolution method, using in-silico tool for Hydrochlorothiazide and Valsartan tablet [Internet]. Pharmaceutics. 2023 ; 15 1-20 art. 1735.[citado 2024 jul. 31 ] Available from: https://doi.org/10.3390/pharmaceutics15061735
    • Vancouver

      Leon RM, Issa MG, Duque MD, Daniel JSP, Ferraz HG. Development of a discriminative dissolution method, using in-silico tool for Hydrochlorothiazide and Valsartan tablet [Internet]. Pharmaceutics. 2023 ; 15 1-20 art. 1735.[citado 2024 jul. 31 ] Available from: https://doi.org/10.3390/pharmaceutics15061735
  • Source: Pharmaceutics. Unidade: FCF

    Subjects: ÓLEOS ESSENCIAIS, COMPOSTOS VOLÁTEIS

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BELEM, Bruna Rodrigues et al. Microemulsions: an encapsulation strategy to increase the thermal stability of D-limonene. Pharmaceutics, v. 15, p. 1-23 art. 2564, 2023Tradução . . Disponível em: https://dx.doi.org/10.3390/pharmaceutics15112564. Acesso em: 31 jul. 2024.
    • APA

      Belem, B. R., Carapeto, G. V., Issa, M. G., & Ferraz, H. G. (2023). Microemulsions: an encapsulation strategy to increase the thermal stability of D-limonene. Pharmaceutics, 15, 1-23 art. 2564. doi:10.3390/pharmaceutics15112564
    • NLM

      Belem BR, Carapeto GV, Issa MG, Ferraz HG. Microemulsions: an encapsulation strategy to increase the thermal stability of D-limonene [Internet]. Pharmaceutics. 2023 ; 15 1-23 art. 2564.[citado 2024 jul. 31 ] Available from: https://dx.doi.org/10.3390/pharmaceutics15112564
    • Vancouver

      Belem BR, Carapeto GV, Issa MG, Ferraz HG. Microemulsions: an encapsulation strategy to increase the thermal stability of D-limonene [Internet]. Pharmaceutics. 2023 ; 15 1-23 art. 2564.[citado 2024 jul. 31 ] Available from: https://dx.doi.org/10.3390/pharmaceutics15112564
  • Source: Pharmaceutics. Unidade: FCF

    Subjects: SISTEMA LINFÁTICO, MEDICAMENTO

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      YOUSEF, Malaz et al. Development of a novel in vitro model to study lymphatic uptake of drugs via artificial chylomicrons. Pharmaceutics, v. 2, p. 1-17 art. 2532, 2023Tradução . . Disponível em: https://dx.doi.org/10.3390/pharmaceutics15112532. Acesso em: 31 jul. 2024.
    • APA

      Yousef, M., Park, C., Henostroza, M., Bou-Chacra, N. A., Davies, N. M., & Löbenberg, R. (2023). Development of a novel in vitro model to study lymphatic uptake of drugs via artificial chylomicrons. Pharmaceutics, 2, 1-17 art. 2532. doi:10.3390/pharmaceutics15112532
    • NLM

      Yousef M, Park C, Henostroza M, Bou-Chacra NA, Davies NM, Löbenberg R. Development of a novel in vitro model to study lymphatic uptake of drugs via artificial chylomicrons [Internet]. Pharmaceutics. 2023 ; 2 1-17 art. 2532.[citado 2024 jul. 31 ] Available from: https://dx.doi.org/10.3390/pharmaceutics15112532
    • Vancouver

      Yousef M, Park C, Henostroza M, Bou-Chacra NA, Davies NM, Löbenberg R. Development of a novel in vitro model to study lymphatic uptake of drugs via artificial chylomicrons [Internet]. Pharmaceutics. 2023 ; 2 1-17 art. 2532.[citado 2024 jul. 31 ] Available from: https://dx.doi.org/10.3390/pharmaceutics15112532
  • Source: Pharmaceutics. Unidade: FCF

    Subjects: MEDICAMENTO GENÉRICO, BIOEQUIVALÊNCIA

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CARAPETO, Gustavo Vaiano et al. Development of Biopredictive dissolution method for extended-release Desvenlafaxine tablets. Pharmaceutics, v. 15, p. 1-14 art. 1544, 2023Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics15051544. Acesso em: 31 jul. 2024.
    • APA

      Carapeto, G. V., Duque, M. D., Issa, M. G., & Ferraz, H. G. (2023). Development of Biopredictive dissolution method for extended-release Desvenlafaxine tablets. Pharmaceutics, 15, 1-14 art. 1544. doi:10.3390/pharmaceutics15051544
    • NLM

      Carapeto GV, Duque MD, Issa MG, Ferraz HG. Development of Biopredictive dissolution method for extended-release Desvenlafaxine tablets [Internet]. Pharmaceutics. 2023 ; 15 1-14 art. 1544.[citado 2024 jul. 31 ] Available from: https://doi.org/10.3390/pharmaceutics15051544
    • Vancouver

      Carapeto GV, Duque MD, Issa MG, Ferraz HG. Development of Biopredictive dissolution method for extended-release Desvenlafaxine tablets [Internet]. Pharmaceutics. 2023 ; 15 1-14 art. 1544.[citado 2024 jul. 31 ] Available from: https://doi.org/10.3390/pharmaceutics15051544
  • Source: Pharmaceutics. Unidades: FCF, ICB

    Subjects: INFECÇÕES OCULARES, ANTIBIÓTICOS, CONJUNTIVITE VIRAL, NANOTECNOLOGIA

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      JESUS, José Izo Santana da Silva de et al. Besifloxacin nanocrystal: towards an innovative ophthalmic preparation. Pharmaceutics, v. 14, p. 1-21 art. 2221, 2022Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics14102221. Acesso em: 31 jul. 2024.
    • APA

      Jesus, J. I. S. da S. de, Lourenço, F. R., Ishida, K., Barreto, T. L., Avino, V. C., Santos Neto, E. dos, & Bou-Chacra, N. A. (2022). Besifloxacin nanocrystal: towards an innovative ophthalmic preparation. Pharmaceutics, 14, 1-21 art. 2221. doi:10.3390/pharmaceutics14102221
    • NLM

      Jesus JIS da S de, Lourenço FR, Ishida K, Barreto TL, Avino VC, Santos Neto E dos, Bou-Chacra NA. Besifloxacin nanocrystal: towards an innovative ophthalmic preparation [Internet]. Pharmaceutics. 2022 ; 14 1-21 art. 2221.[citado 2024 jul. 31 ] Available from: https://doi.org/10.3390/pharmaceutics14102221
    • Vancouver

      Jesus JIS da S de, Lourenço FR, Ishida K, Barreto TL, Avino VC, Santos Neto E dos, Bou-Chacra NA. Besifloxacin nanocrystal: towards an innovative ophthalmic preparation [Internet]. Pharmaceutics. 2022 ; 14 1-21 art. 2221.[citado 2024 jul. 31 ] Available from: https://doi.org/10.3390/pharmaceutics14102221
  • Source: Pharmaceutics. Unidade: FCF

    Subjects: INDÚSTRIA FARMACÊUTICA, MEDICAMENTO, BIOEQUIVALÊNCIA, FORMAS FARMACÊUTICAS

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ISSA, Michele Georges et al. Development of extended-release mini-tablets containing metoprolol supported by design of experiments and physiologically based biopharmaceutics modeling. Pharmaceutics, v. 14, p. 1-21 art. 892, 2022Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics14050892. Acesso em: 31 jul. 2024.
    • APA

      Issa, M. G., Souza, N. V. de, Jou, B. W. C., Duque, M. D., & Ferraz, H. G. (2022). Development of extended-release mini-tablets containing metoprolol supported by design of experiments and physiologically based biopharmaceutics modeling. Pharmaceutics, 14, 1-21 art. 892. doi:10.3390/pharmaceutics14050892
    • NLM

      Issa MG, Souza NV de, Jou BWC, Duque MD, Ferraz HG. Development of extended-release mini-tablets containing metoprolol supported by design of experiments and physiologically based biopharmaceutics modeling [Internet]. Pharmaceutics. 2022 ; 14 1-21 art. 892.[citado 2024 jul. 31 ] Available from: https://doi.org/10.3390/pharmaceutics14050892
    • Vancouver

      Issa MG, Souza NV de, Jou BWC, Duque MD, Ferraz HG. Development of extended-release mini-tablets containing metoprolol supported by design of experiments and physiologically based biopharmaceutics modeling [Internet]. Pharmaceutics. 2022 ; 14 1-21 art. 892.[citado 2024 jul. 31 ] Available from: https://doi.org/10.3390/pharmaceutics14050892
  • Source: Pharmaceutics. Unidade: FCF

    Subjects: ANTI-INFLAMATÓRIOS, FÁRMACOS

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SILVA, Daniela Amaral et al. Biphasic dissolution as an exploratory method during early drug product development. Pharmaceutics, v. 12, p. 1-17 art, 2020Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics12050420. Acesso em: 31 jul. 2024.
    • APA

      Silva, D. A., Gousous, J. A., Davies, N. M., Bou-Chacra, N. A., Webster, G. K., Lipka, E., et al. (2020). Biphasic dissolution as an exploratory method during early drug product development. Pharmaceutics, 12, 1-17 art. doi:10.3390/pharmaceutics12050420
    • NLM

      Silva DA, Gousous JA, Davies NM, Bou-Chacra NA, Webster GK, Lipka E, Amidon GL, Löbenberg R. Biphasic dissolution as an exploratory method during early drug product development [Internet]. Pharmaceutics. 2020 ; 12 1-17 art.[citado 2024 jul. 31 ] Available from: https://doi.org/10.3390/pharmaceutics12050420
    • Vancouver

      Silva DA, Gousous JA, Davies NM, Bou-Chacra NA, Webster GK, Lipka E, Amidon GL, Löbenberg R. Biphasic dissolution as an exploratory method during early drug product development [Internet]. Pharmaceutics. 2020 ; 12 1-17 art.[citado 2024 jul. 31 ] Available from: https://doi.org/10.3390/pharmaceutics12050420
  • Source: Pharmaceutics. Unidade: FCF

    Subjects: BAGAÇOS, UVA, FENÓIS, FILTRO SOLAR, ENSAIO CLÍNICO

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      HÜBNER, Alexandra de Almeida et al. Safety and potoprotective efficacy of a sunscreen system based on grape pomace (Vitis vinifera L.) phenolics from winemaking. Pharmaceutics, v. 12, p. 1-22 art. 1148, 2020Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics12121148. Acesso em: 31 jul. 2024.
    • APA

      Hübner, A. de A., Sarruf, F. D., Oliveira, C. A., Neto, A. V., Fischer, D. C. H., Kato, E. T. M., et al. (2020). Safety and potoprotective efficacy of a sunscreen system based on grape pomace (Vitis vinifera L.) phenolics from winemaking. Pharmaceutics, 12, 1-22 art. 1148. doi:10.3390/pharmaceutics12121148
    • NLM

      Hübner A de A, Sarruf FD, Oliveira CA, Neto AV, Fischer DCH, Kato ETM, Lourenço FR, Baby AR, Bacchi EM. Safety and potoprotective efficacy of a sunscreen system based on grape pomace (Vitis vinifera L.) phenolics from winemaking [Internet]. Pharmaceutics. 2020 ; 12 1-22 art. 1148.[citado 2024 jul. 31 ] Available from: https://doi.org/10.3390/pharmaceutics12121148
    • Vancouver

      Hübner A de A, Sarruf FD, Oliveira CA, Neto AV, Fischer DCH, Kato ETM, Lourenço FR, Baby AR, Bacchi EM. Safety and potoprotective efficacy of a sunscreen system based on grape pomace (Vitis vinifera L.) phenolics from winemaking [Internet]. Pharmaceutics. 2020 ; 12 1-22 art. 1148.[citado 2024 jul. 31 ] Available from: https://doi.org/10.3390/pharmaceutics12121148
  • Source: Pharmaceutics. Unidade: FCF

    Subjects: BIOEQUIVALÊNCIA, FARMACOCINÉTICA

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      DUQUE, Marcelo Dutra et al. In silico prediction of plasma concentrations of Fluconazole capsules with different dissolution profiles and bioequivalence study using population simulation. Pharmaceutics, v. 11, p. 1-12 art. 215, 2019Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics11050215. Acesso em: 31 jul. 2024.
    • APA

      Duque, M. D., Silva, D. A., Issa, M. G., Porta, V., Löbenberg, R., & Ferraz, H. G. (2019). In silico prediction of plasma concentrations of Fluconazole capsules with different dissolution profiles and bioequivalence study using population simulation. Pharmaceutics, 11, 1-12 art. 215. doi:10.3390/pharmaceutics11050215
    • NLM

      Duque MD, Silva DA, Issa MG, Porta V, Löbenberg R, Ferraz HG. In silico prediction of plasma concentrations of Fluconazole capsules with different dissolution profiles and bioequivalence study using population simulation [Internet]. Pharmaceutics. 2019 ; 11 1-12 art. 215.[citado 2024 jul. 31 ] Available from: https://doi.org/10.3390/pharmaceutics11050215
    • Vancouver

      Duque MD, Silva DA, Issa MG, Porta V, Löbenberg R, Ferraz HG. In silico prediction of plasma concentrations of Fluconazole capsules with different dissolution profiles and bioequivalence study using population simulation [Internet]. Pharmaceutics. 2019 ; 11 1-12 art. 215.[citado 2024 jul. 31 ] Available from: https://doi.org/10.3390/pharmaceutics11050215
  • Source: Pharmaceutics. Unidade: FCF

    Subjects: MACROMOLÉCULA, NANOCOMPOSITOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      GONZAGA, Rodrigo Vieira et al. Targeting groups employed in selective dendrons and dendrimers. Pharmaceutics, v. 10, n. 4, p. 1-27 art. 219, 2018Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics10040219. Acesso em: 31 jul. 2024.
    • APA

      Gonzaga, R. V., Santos, S. da S., Silva, J. V. da, Prieto, D. C., Savino, D. F., Giarolla, J., & Ferreira, E. I. (2018). Targeting groups employed in selective dendrons and dendrimers. Pharmaceutics, 10( 4), 1-27 art. 219. doi:10.3390/pharmaceutics10040219
    • NLM

      Gonzaga RV, Santos S da S, Silva JV da, Prieto DC, Savino DF, Giarolla J, Ferreira EI. Targeting groups employed in selective dendrons and dendrimers [Internet]. Pharmaceutics. 2018 ; 10( 4): 1-27 art. 219.[citado 2024 jul. 31 ] Available from: https://doi.org/10.3390/pharmaceutics10040219
    • Vancouver

      Gonzaga RV, Santos S da S, Silva JV da, Prieto DC, Savino DF, Giarolla J, Ferreira EI. Targeting groups employed in selective dendrons and dendrimers [Internet]. Pharmaceutics. 2018 ; 10( 4): 1-27 art. 219.[citado 2024 jul. 31 ] Available from: https://doi.org/10.3390/pharmaceutics10040219
  • Source: Pharmaceutics. Unidade: FCF

    Subjects: LÍQUIDOS IÔNICOS, SOLUBILIDADE

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CAPARICA, Rita et al. Choline-amino acid ionic liquids as green functional excipients to enhance drug solubility. Pharmaceutics, v. 10, n. 4, p. 2-13 art. 288, 2018Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics10040288. Acesso em: 31 jul. 2024.
    • APA

      Caparica, R., Júlio, A., Baby, A. R., Araújo, M. E. M., Fernandes, A. S., Costa, J. G., & Almeida, T. S. de. (2018). Choline-amino acid ionic liquids as green functional excipients to enhance drug solubility. Pharmaceutics, 10( 4), 2-13 art. 288. doi:10.3390/pharmaceutics10040288
    • NLM

      Caparica R, Júlio A, Baby AR, Araújo MEM, Fernandes AS, Costa JG, Almeida TS de. Choline-amino acid ionic liquids as green functional excipients to enhance drug solubility [Internet]. Pharmaceutics. 2018 ; 10( 4): 2-13 art. 288.[citado 2024 jul. 31 ] Available from: https://doi.org/10.3390/pharmaceutics10040288
    • Vancouver

      Caparica R, Júlio A, Baby AR, Araújo MEM, Fernandes AS, Costa JG, Almeida TS de. Choline-amino acid ionic liquids as green functional excipients to enhance drug solubility [Internet]. Pharmaceutics. 2018 ; 10( 4): 2-13 art. 288.[citado 2024 jul. 31 ] Available from: https://doi.org/10.3390/pharmaceutics10040288

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024